Evaluation of the Use of Synthetic Glue for Mesh Fixation in Laparoscopic Sacrocolpopexy
Launched by BRNO UNIVERSITY HOSPITAL · Mar 10, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method of fixing a mesh implant during a surgery called laparoscopic sacrocolpopexy, which is a common treatment for a condition known as apical prolapse. The aim is to see if using a special glue, called cyanoacrylate adhesive, can make the surgery faster and safer compared to traditional stitching methods. While laparoscopic sacrocolpopexy is effective, it often takes a long time to perform, which can increase the risk of complications. The researchers want to find out if this glue can shorten the surgery time while still ensuring good results and safety for patients.
To be eligible for this study, participants should be women aged 18 to 75 who have a moderate to severe pelvic organ prolapse. They should also be able to understand Czech and need the surgery for their condition. However, women who want to keep their uterus, those who have already had a hysterectomy, or those with certain health issues related to their reproductive organs cannot participate. If you join the study, you will receive either the new glue method or the traditional stitching method during surgery, and your recovery will be monitored for any complications or discomfort. This trial is important as it is the first of its kind to compare these two techniques directly.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Sufficient knowledge of the Czech language
- • Pelvic organs prolapse of second stage or higher according to POPQ classification (POPQ ≥ 2)
- • Patients indicated for laparoscopic sacropexy - sacrocervicopexy with concomitant supracervical hysterectomy
- Exclusion Criteria:
- • Patients requesting uterine preservation
- • Patients with previous hysterectomy
- • Patients with premalignancy or malignancy of the female reproductive organs
- • Concomitant urethropexy
About Brno University Hospital
Brno University Hospital is a leading clinical research institution based in the Czech Republic, dedicated to advancing medical knowledge and patient care through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, the hospital harnesses the expertise of its diverse medical staff and state-of-the-art facilities to conduct high-quality studies across various therapeutic areas. Committed to ethical standards and patient safety, Brno University Hospital plays a pivotal role in translating scientific discoveries into effective treatments, contributing significantly to the advancement of healthcare both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brno, Czech Republic, Czechia
Patients applied
Trial Officials
Samuel Tvarozek, MD
Principal Investigator
Department of Obstetrics and Gynecology, University Hospital Brno, Brno, Czech Republic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported